#United States #New York #Wegovy #Ro #NovoCare

Ro and NovoCare® Pharmacy Integration: A Game Changer for Obesity Treatment

In an exciting development for patients seeking effective obesity treatment, Ro has announced a pioneering integration with NovoCare® Pharmacy, which allows for seamless access to Wegovy®—the FDA-approved GLP-1 medication. Within Ro's user-friendly app, patients can now obtain this critical medication at the lowest possible cash price, set at $499 per month.

This integration is revolutionary, offering a unique experience where patients never need to leave the Ro app to manage their prescription. By partnering directly with Novo Nordisk's NovoCare® Pharmacy, Ro is addressing a significant need in the healthcare market by providing a reliable supply of this important medication effectively and affordably. As Ro's co-founder and CEO Zach Reitano stated, "Fighting for patients means making it as easy and affordable as possible to access high-quality treatment."

Enhancing Patient Care

Ro is dedicated to transforming the healthcare landscape to enhance accessibility and affordability for its users. Patients can consult with licensed healthcare providers directly through the app, ensuring a comprehensive support system. This includes not just prescriptions but also a range of services such as personalized coaching, educational resources, and ongoing monitoring of their health journey.

With Ro's integrated approach, obesity care becomes more complete, offering features tailored for weight management, including:

• - 24/7 messaging for any queries
• - Regular check-ins and support for dosage adjustments
• - Extensive educational content regarding health and wellness
• - Lab services to monitor health improvements

Having a streamlined solution allows patients to tackle obesity with ease, providing crucial support where it's needed most. This thoughtful integration simplifies the process and eliminates the complexity typically associated with managing multiple healthcare touchpoints.

Comprehensive Approach to Treatment

The inclusion of Wegovy® into Ro's obesity care formulary emphasizes the company's commitment to providing an extensive selection of treatments to its users. The app ensures that patients can either opt for cash payments or use their health insurance to manage costs effectively. Through the Ro Insurance Checker, users can verify health benefits for free, allowing them to choose the best medication option.

Ro's innovative approach to care is highlighted by its direct-to-patient model that delivers high-quality healthcare services without the barriers often experienced in traditional healthcare settings. Since its inception, Ro has already impacted millions of lives and has been instrumental in extending care to underserved areas across the nation.

The direct availability of Wegovy® through this partnership is particularly vital for uninsured patients who may previously have struggled to access effective treatment options. Ro is scaling this model to address obesity, a constant challenge affecting numerous individuals throughout the United States.

Conclusion

With the recent integration of NovoCare® Pharmacy into Ro's platform, patients can finally access high-quality, affordable obesity treatment with unprecedented ease. This initiative not only underscores Ro's dedication to patient care but also sets a precedent for how telehealth can revolutionize access to effective healthcare solutions. As they continue to grow and enhance their services, Ro promises a brighter, healthier future for many individuals striving to meet their health goals, one app at a time.